TP53 and head and neck cancer: Previous studies demonstrated that alternative splice variants (E6*) are the dominant E6 transcripts in HPV associated head and neck cancer, preventing E6-E6AP-p53 complex formation and inhibiting p53 degradation (36, –, 41).